v3.19.3.a.u2
CONDENSED CONSOLIDATING FINANCIAL STATEMENTS Table 4 - Condensed Consolidating Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 26, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   $ 508,757 $ 544,207 $ 406,799
Cash flows from investing activities:        
Capital expenditures   (533,568) (457,452) (384,638)
Change in accounts payable related to capital expenditures   (12,731) (7,683) 36,903
Acquisitions   0 (37,502) (1,461,719)
Proceeds from Axeon term loan   0 0 110,000
Proceeds from insurance recoveries   0 78,419 977
Proceeds from sale or disposition of assets   228,152 270,440 2,036
Investment in subsidiaries   0 0 0
Other, net   (1,100) 0 0
Net cash (used in) provided by investing activities   (319,247) (153,778) (1,696,441)
Cash flows from financing activities:        
Debt borrowings   1,458,380 1,872,653 3,060,100
Debt repayments   (1,249,400) (2,381,776) (2,487,539)
Proceeds from issuance of Series D preferred units   0 590,000 0
Payment of issuance costs for Series D preferred units   0 (34,203) 0
Proceeds from issuance of other preferred units, net of issuance costs   0 0 538,560
Proceeds from issuance of common units, net of issuance costs $ 15,000 15,000 10,000 643,878
Contributions from general partner   0 204 13,737
Distributions to preferred unitholders   (121,693) (90,670) (38,833)
Distributions to common unitholders and general partner   (258,354) (300,777) (446,306)
Cash consideration for Merger (Note 4)   0 (67,795) 0
Proceeds from termination of interest rate swaps   0 8,048 0
Contributions from (distributions to) affiliates   0 0 0
Net intercompany activity   0 0 0
Other, net   (21,583) (5,551) (7,325)
Net cash provided by (used in) financing activities   (177,650) (399,867) 1,276,272
Effect of foreign exchange rate changes on cash   (524) (1,210) 1,720
Net increase (decrease) in cash, cash equivalents and restricted cash   11,336 (10,648) (11,650)
Cash, cash equivalents and restricted cash as of the beginning of the period   13,644 24,292 35,942
Cash, cash equivalents and restricted cash as of the end of the period   24,980 13,644 24,292
Eliminations        
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   (570,090) (694,859) (737,138)
Cash flows from investing activities:        
Capital expenditures   0 0 0
Change in accounts payable related to capital expenditures   0 0 0
Acquisitions     0 0
Proceeds from Axeon term loan       0
Proceeds from insurance recoveries     0 0
Proceeds from sale or disposition of assets   0 0 0
Investment in subsidiaries   11,999 2,529,840 1,262,126
Other, net   0    
Net cash (used in) provided by investing activities   11,999 2,529,840 1,262,126
Cash flows from financing activities:        
Debt borrowings   0 0 0
Debt repayments   0 0 0
Proceeds from issuance of Series D preferred units     0  
Payment of issuance costs for Series D preferred units     0  
Proceeds from issuance of other preferred units, net of issuance costs       0
Proceeds from issuance of common units, net of issuance costs   0 0 0
Contributions from general partner     0 0
Distributions to preferred unitholders   182,546 136,007 58,251
Distributions to common unitholders and general partner   387,544 451,184 669,482
Cash consideration for Merger (Note 4)     0  
Proceeds from termination of interest rate swaps     0  
Contributions from (distributions to) affiliates   (11,999) (2,422,172) (1,252,721)
Net intercompany activity   0 0 0
Other, net   0 0 0
Net cash provided by (used in) financing activities   558,091 (1,834,981) (524,988)
Effect of foreign exchange rate changes on cash   0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash   0 0 0
Cash, cash equivalents and restricted cash as of the beginning of the period   0 0 0
Cash, cash equivalents and restricted cash as of the end of the period   0 0 0
Parent Company Guarantor [Member] | NuStar Energy | Reportable Legal Entities [Member]        
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   376,999 444,233 483,481
Cash flows from investing activities:        
Capital expenditures   0 0 0
Change in accounts payable related to capital expenditures   0 0 0
Acquisitions     0 0
Proceeds from Axeon term loan       0
Proceeds from insurance recoveries     0 0
Proceeds from sale or disposition of assets   0 0 0
Investment in subsidiaries   0 (708,600) (1,262,000)
Other, net   0    
Net cash (used in) provided by investing activities   0 (708,600) (1,262,000)
Cash flows from financing activities:        
Debt borrowings   0 0 0
Debt repayments   0 0 0
Proceeds from issuance of Series D preferred units     590,000  
Payment of issuance costs for Series D preferred units     (34,203)  
Proceeds from issuance of other preferred units, net of issuance costs       538,560
Proceeds from issuance of common units, net of issuance costs   15,000 10,000 643,878
Contributions from general partner     204 13,737
Distributions to preferred unitholders   (121,693) (90,670) (38,833)
Distributions to common unitholders and general partner   (258,354) (300,777) (446,306)
Cash consideration for Merger (Note 4)     (67,936)  
Proceeds from termination of interest rate swaps     0  
Contributions from (distributions to) affiliates   0 0 0
Net intercompany activity   (2,010) 162,498 73,206
Other, net   (11,021) (4,379) (5,708)
Net cash provided by (used in) financing activities   (378,078) 264,737 778,534
Effect of foreign exchange rate changes on cash   0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash   (1,079) 370 15
Cash, cash equivalents and restricted cash as of the beginning of the period   1,255 885 870
Cash, cash equivalents and restricted cash as of the end of the period   176 1,255 885
Subsidiary Issuer [Member] | NuStar Logistics | Reportable Legal Entities [Member]        
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   166,005 100,385 152,101
Cash flows from investing activities:        
Capital expenditures   (257,117) (71,044) (47,600)
Change in accounts payable related to capital expenditures   1,369 11,101 (1,988)
Acquisitions     0 0
Proceeds from Axeon term loan       110,000
Proceeds from insurance recoveries     0 0
Proceeds from sale or disposition of assets   247 2,674 1,955
Investment in subsidiaries   (11,999) (1,711,975) 0
Other, net   0    
Net cash (used in) provided by investing activities   (267,500) (1,769,244) 62,367
Cash flows from financing activities:        
Debt borrowings   1,415,580 1,840,853 2,969,400
Debt repayments   (1,207,000) (2,349,476) (2,400,739)
Proceeds from issuance of Series D preferred units     0  
Payment of issuance costs for Series D preferred units     0  
Proceeds from issuance of other preferred units, net of issuance costs       0
Proceeds from issuance of common units, net of issuance costs   0 0 0
Contributions from general partner     0 0
Distributions to preferred unitholders   (60,846) (45,336) (19,417)
Distributions to common unitholders and general partner   (129,177) (150,388) (223,153)
Cash consideration for Merger (Note 4)     0  
Proceeds from termination of interest rate swaps     8,048  
Contributions from (distributions to) affiliates   0 599,400 1,262,000
Net intercompany activity   101,980 1,766,881 (1,801,218)
Other, net   (10,281) (1,101) (1,317)
Net cash provided by (used in) financing activities   110,256 1,668,881 (214,444)
Effect of foreign exchange rate changes on cash   0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash   8,761 22 24
Cash, cash equivalents and restricted cash as of the beginning of the period   51 29 5
Cash, cash equivalents and restricted cash as of the end of the period   8,812 51 29
Guarantor Subsidiaries [Member] | NuPOP | Reportable Legal Entities [Member]        
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   126,728 179,512 102,405
Cash flows from investing activities:        
Capital expenditures   (28,592) (19,152) (35,041)
Change in accounts payable related to capital expenditures   1,212 (5,161) 5,964
Acquisitions     (37,502) 0
Proceeds from Axeon term loan       0
Proceeds from insurance recoveries     0 0
Proceeds from sale or disposition of assets   90 31 18
Investment in subsidiaries   0 (54,600) 0
Other, net   0    
Net cash (used in) provided by investing activities   (27,290) (116,384) (29,059)
Cash flows from financing activities:        
Debt borrowings   0 0 0
Debt repayments   0 0 0
Proceeds from issuance of Series D preferred units     0  
Payment of issuance costs for Series D preferred units     0  
Proceeds from issuance of other preferred units, net of issuance costs       0
Proceeds from issuance of common units, net of issuance costs   0 0 0
Contributions from general partner     0 0
Distributions to preferred unitholders   (60,847) (45,336) (19,416)
Distributions to common unitholders and general partner   (129,177) (150,388) (223,153)
Cash consideration for Merger (Note 4)     0  
Proceeds from termination of interest rate swaps     0  
Contributions from (distributions to) affiliates   0 54,600 0
Net intercompany activity   90,734 77,996 169,223
Other, net   (148) 0 0
Net cash provided by (used in) financing activities   (99,438) (63,128) (73,346)
Effect of foreign exchange rate changes on cash   0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash   0 0 0
Cash, cash equivalents and restricted cash as of the beginning of the period   0 0 0
Cash, cash equivalents and restricted cash as of the end of the period   0 0 0
Non-Guarantor Subsidiaries | Reportable Legal Entities [Member]        
Cash flows from operating activities:        
Net cash provided by (used in) operating activities   409,115 514,936 405,950
Cash flows from investing activities:        
Capital expenditures   (247,859) (367,256) (301,997)
Change in accounts payable related to capital expenditures   (15,312) (13,623) 32,927
Acquisitions     0 (1,461,719)
Proceeds from Axeon term loan       0
Proceeds from insurance recoveries     78,419 977
Proceeds from sale or disposition of assets   227,815 267,735 63
Investment in subsidiaries   0 (54,665) (126)
Other, net   (1,100)    
Net cash (used in) provided by investing activities   (36,456) (89,390) (1,729,875)
Cash flows from financing activities:        
Debt borrowings   42,800 31,800 90,700
Debt repayments   (42,400) (32,300) (86,800)
Proceeds from issuance of Series D preferred units     0  
Payment of issuance costs for Series D preferred units     0  
Proceeds from issuance of other preferred units, net of issuance costs       0
Proceeds from issuance of common units, net of issuance costs   0 0 0
Contributions from general partner     0 0
Distributions to preferred unitholders   (60,853) (45,335) (19,418)
Distributions to common unitholders and general partner   (129,190) (150,408) (223,176)
Cash consideration for Merger (Note 4)     141  
Proceeds from termination of interest rate swaps     0  
Contributions from (distributions to) affiliates   11,999 1,768,172 (9,279)
Net intercompany activity   (190,704) (2,007,375) 1,558,789
Other, net   (133) (71) (300)
Net cash provided by (used in) financing activities   (368,481) (435,376) 1,310,516
Effect of foreign exchange rate changes on cash   (524) (1,210) 1,720
Net increase (decrease) in cash, cash equivalents and restricted cash   3,654 (11,040) (11,689)
Cash, cash equivalents and restricted cash as of the beginning of the period   12,338 23,378 35,067
Cash, cash equivalents and restricted cash as of the end of the period   $ 15,992 $ 12,338 $ 23,378